NMN which has the full name β-nicotinamide mononucleotide is the precursor of nicotinamide adenine dinucleotide (NAD+) (coenzyme I) in human cells. Inside the human body, NMN plays an important role in energy and material metabolism. By applying advanced technology, Abiochem has successfully developed a novel in vitro biosynthetic route of NMN with fully independent intellectual property rights.

As the 3rd largest solid component in human breast milk right after lactose and fat, Human Milk Oligosaccharides (HMOs) can promote the growth of probiotics and are widely used in infant/baby formulae as an additive. More than 200 different HMOs have been identified. Based on its innovation platforms such as “Intelligent Design”, “Enzyme Engineering”, “Genetic Engineering”, “Cell Foundry” and “Fermentation Engineering” and by applying advanced biosynthetic technology, Abiochem has successfully constructed the cell factory for the high-performance bio-manufacturing of HMOs series products, such as 2'-FL, with independent intellectual property rights.

Allulose is a rare six-carbon ketose, which is hardly metabolized after intestinal absorption and does not provide calories or raise blood glucose, therefore is considered an attractive sugar substitute. Based on its “Intelligent Design” and “Enzyme Engineering” platforms, Abiochem has developed a proprietary high-performance enzyme and in vitro biosynthesis technique for the efficient biosynthesis of Allulose. This biosynthetic method for Allulose has the significant advantages such as high efficiency, low production cost, environmentally friendly production, and strong stability, etc.